Inhaled iloprost improves gas exchange in patients with COVID-19 and acute respiratory distress syndrome
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Inhaled iloprost improves gas exchange in patients with COVID-19 and acute respiratory distress syndrome ; volume:25 ; number:1 ; day:21 ; month:7 ; year:2021 ; pages:1-3 ; date:12.2021
Critical care ; 25, Heft 1 (21.7.2021), 1-3, 12.2021
- Creator
-
Tsareva, Natalia A.
Avdeev, Sergey N.
Kosanovic, Djuro
Schermuly, Ralph Theo
Trushenko, Natalia V.
Nekludova, Galina V.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-021-03690-7
- URN
-
urn:nbn:de:101:1-2021102301550104024750
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tsareva, Natalia A.
- Avdeev, Sergey N.
- Kosanovic, Djuro
- Schermuly, Ralph Theo
- Trushenko, Natalia V.
- Nekludova, Galina V.
- SpringerLink (Online service)
Other Objects (12)
Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale
Inhaled prostacyclin therapy in the acute respiratory distress syndrome : a randomized controlled multicenter trial
Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial
Acute hemodynamic effect of inhaled iloprost in pulmonary artery hypertension evaluated with echocardiography
A lung rescue team improves survival in obesity with acute respiratory distress syndrome
Inhaled protein/peptide-based therapies for respiratory disease
Association between inhaled nitric oxide treatment and long-term pulmonary function in survivors of acute respiratory distress syndrome
Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome
Efficacy of inhaled iloprost in children with pulmonary hypertension after pediatric cardiac surgery: a case series
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study
Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study
Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale
Inhaled prostacyclin therapy in the acute respiratory distress syndrome : a randomized controlled multicenter trial
Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial
Acute hemodynamic effect of inhaled iloprost in pulmonary artery hypertension evaluated with echocardiography
A lung rescue team improves survival in obesity with acute respiratory distress syndrome
Inhaled protein/peptide-based therapies for respiratory disease
Association between inhaled nitric oxide treatment and long-term pulmonary function in survivors of acute respiratory distress syndrome
Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome
Efficacy of inhaled iloprost in children with pulmonary hypertension after pediatric cardiac surgery: a case series
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study
Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study
Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale
Inhaled prostacyclin therapy in the acute respiratory distress syndrome : a randomized controlled multicenter trial
Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial
Acute hemodynamic effect of inhaled iloprost in pulmonary artery hypertension evaluated with echocardiography
A lung rescue team improves survival in obesity with acute respiratory distress syndrome
Inhaled protein/peptide-based therapies for respiratory disease
Association between inhaled nitric oxide treatment and long-term pulmonary function in survivors of acute respiratory distress syndrome
Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome
Efficacy of inhaled iloprost in children with pulmonary hypertension after pediatric cardiac surgery: a case series
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study